Zobrazeno 1 - 10
of 324
pro vyhledávání: '"C, von Bahr"'
Publikováno v:
Acta Pharmacologica et Toxicologica. 49:200-204
Barbiturate treatment can enhance drug oxidation in man, but its effects on glucuronidation of clinically used drugs are unknown. We have studied the effect of 10 days treatment with pentobarbital on oxazepam glucuronidation in six volunteers. The di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4657d02039f1e93fc17ac1a89cfc282
https://doi.org/10.1111/j.1600-0773.1981.tb00893.x
https://doi.org/10.1111/j.1600-0773.1981.tb00893.x
Publikováno v:
European Journal of Clinical Pharmacology. 56:123-127
Objective: The nocturnal serum melatonin (MT) level increases after ingestion of fluvoxamine (FLU) – a selective serotonin re-uptake inhibitor (SSRI) with antidepressive properties. The mechanism behind the MT increase is unknown. Citalopram (CIT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae01da3e5b615de437919422791d585a
https://doi.org/10.1007/s002280050729
https://doi.org/10.1007/s002280050729
Fibrinolytic treatment in suspected acute myocardial infarction - use and risks in clinical practice
Publikováno v:
European Journal of Clinical Pharmacology. 52:179-182
To study the adherence to guidelines concerning fibrinolytic treatment of patients with suspected myocardial infarction and to obtain information on severe events in clinical practice.Prospective reporting of all patients admitted for suspected acute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c41df6a264bba00bf773a2b926715323
https://doi.org/10.1007/s002280050271
https://doi.org/10.1007/s002280050271
Publikováno v:
British Journal of Clinical Pharmacology. 39:503-510
1. The prolactin response following administration of the D2-dopamine receptor antagonist remoxipride was studied in eight healthy male volunteers. The purpose of the study was to investigate the duration of a refractory period of prolactin release f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::596c1b6d21e1f8aad14e699ef2cb95b8
https://doi.org/10.1111/j.1365-2125.1995.tb04487.x
https://doi.org/10.1111/j.1365-2125.1995.tb04487.x
Publikováno v:
Psychopharmacology. 111:27-32
Twelve healthy male volunteers took part in a double-blind randomised cross-over study composed of three treatment sessions: remoxipride 100 mg; remoxipride 100 mg plus biperiden 4 mg; and biperiden 4 mg. Plasma and urine concentrations of remoxiprid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c3bfcaba4e8d81ba04c8851f1a7819
https://doi.org/10.1007/bf02257403
https://doi.org/10.1007/bf02257403
Autor:
J.-O. Svensson, T. Hansson, Jan Lundström, C. Von Bahr, Magnus Ingelman-Sundberg, M. Marklund
Publikováno v:
Pharmacology & Toxicology. 71:416-419
Incubation of the tricyclic antidepressant desmethylimpramine (DMI) with rat liver or brain microsomes in the presence of NADPH or t-butyl-hydroperoxide (TBH) revealed different regiospecificities in the hydroxylation reactions between the tissues. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd488f04a45a56af70202b7e91c3c3b
https://doi.org/10.1111/j.1600-0773.1992.tb00571.x
https://doi.org/10.1111/j.1600-0773.1992.tb00571.x
Publikováno v:
Psychopharmacology. 103:443-448
Six female and six male healthy volunteers received 100 mg remoxipride, 200 mg sulpiride and placebo as single oral doses in a double blind trial with a randomized crossover design. The main objective was to compare the effect of the two drugs on ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef550ad836fa211420e0a9ba2499738
https://doi.org/10.1007/bf02244242
https://doi.org/10.1007/bf02244242
Publikováno v:
Psychopharmacology. 103:46-49
The pharmacokinetics of remoxipride, a new selective dopamine-D2 receptor antagonist with antipsychotic action, was evaluated in eight elderly psychiatric patients with tardive dyskinesia (TD). The daily oral doses of remoxipride were gradually incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f5784b6a6eb5a1bbbf3c8f732a91f6
https://doi.org/10.1007/bf02244072
https://doi.org/10.1007/bf02244072
Autor:
Lars Farde, C. Von Bahr
Publikováno v:
Acta Psychiatrica Scandinavica. 82:67-71
Remoxipride is a new antipsychotic drug that binds selectively to the D2-dopamine receptor subtype as demonstrated in animal studies in vitro and in vivo. It is generally assumed that the antipsychotic effect of neuroleptic drugs is mediated by block
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16f64e491a356efb5577145e4b51bbf
https://doi.org/10.1111/j.1600-0447.1990.tb05292.x
https://doi.org/10.1111/j.1600-0447.1990.tb05292.x
Publikováno v:
Value in Health. 5(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e4d4d761789bcbeca50cbf2fee7898